1. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities;Varga;J Scleroderma Relat Disord,2017
2. A series of reports from the U.S. Food and Drug Administration's (FDA's) Patient-Focused Drug Development Initiative [June 30, 2021:[Available from: https://www.fda.gov/media/150454/download.
3. Management of calcinosis cutis in rheumatic diseases;Elahmar;J Rheumatol,2022
4. Calcinosis in rheumatic diseases;Boulman;Semin Arthritis Rheum,2005
5. Calcinosis in scleroderma made crystal clear;Hsu;Curr Opin Rheumatol,2019